🇺🇸 FDA
Patent

US 11186622

PAC1 receptor agonists (MAXCAPS) and uses thereof

granted A61KA61K31/4985A61K38/00

Quick answer

US patent 11186622 (PAC1 receptor agonists (MAXCAPS) and uses thereof) held by The United States Government represented by the Department of Veterans Affairs expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States Government represented by the Department of Veterans Affairs
Grant date
Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4985, A61K38/00, A61K38/2278, A61K47/60